» Articles » PMID: 35586306

Risperidone-induced Neuroleptic Malignant Syndrome: a Case Report

Overview
Specialty Psychiatry
Date 2022 May 19
PMID 35586306
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroleptic malignant syndrome (NMS) is a rare illness that results from reactions to antipsychotics. However, the diagnosis of NMS is challenging due to its atypical clinical presentation and unclear pathogenesis. We report the case of a patient with NMS induced by irregular use of antipsychotics, especially risperidone (RSP). He had typical hyperthermia, muscle rigidity and rhabdomyolysis, which led to renal impairment. We carefully analysed the mechanism by which NMS occurred in this patient. An interesting aspect of the case is the synergistic involvement of risperidone, antidepressants, opioids and stress. Because of these complex predisposing factors, it is difficult to completely rule out the diagnosis of malignant hyperthermia (MH). In addition, the rare phenomenon of elevated lipase and amylase was observed in this patient.

References
1.
Ghio L, Fornaro G, Rossi P . Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report. J Clin Psychopharmacol. 2009; 29(4):391-2. DOI: 10.1097/JCP.0b013e3181ad2064. View

2.
Dunkley E, Isbister G, Sibbritt D, Dawson A, Whyte I . The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003; 96(9):635-42. DOI: 10.1093/qjmed/hcg109. View

3.
Vaidyanathan S, Subramanian K, Bharadwaj B, Das S, Kola G, Maroju N . Acute Necrotizing Pancreatitis Associated With Orally Disintegrating Formulation of Olanzapine: Implications on Clinical Presentation and Management. J Clin Psychopharmacol. 2019; 39(5):519-521. DOI: 10.1097/JCP.0000000000001081. View

4.
Kawabe K, Ueno S . A case of acute pancreatitis associated with risperidone treatment. Clin Psychopharmacol Neurosci. 2014; 12(1):67-8. PMC: 4022769. DOI: 10.9758/cpn.2014.12.1.67. View

5.
Uguz F, Sonmez E . Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report. Gen Hosp Psychiatry. 2013; 35(3):327.e7-327.e8. DOI: 10.1016/j.genhosppsych.2012.11.004. View